tradingkey.logo

Fortrea Holdings Inc

FTRE
9.668USD
-0.452-4.47%
Cierre 11/03, 16:00ETCotizaciones retrasadas 15 min
877.85MCap. mercado
PérdidaP/E TTM

Fortrea Holdings Inc

9.668
-0.452-4.47%

Más Datos de Fortrea Holdings Inc Compañía

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Información de Fortrea Holdings Inc

Símbolo de cotizaciónFTRE
Nombre de la empresaFortrea Holdings Inc
Fecha de salida a bolsaJun 16, 2023
Director ejecutivoMr. Anshul Thakrala
Número de empleados15500
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 16
Dirección8 Moore Drive
CiudadDURHAM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal27709
Teléfono18774950816
Sitio Webhttps://www.fortrea.com/
Símbolo de cotizaciónFTRE
Fecha de salida a bolsaJun 16, 2023
Director ejecutivoMr. Anshul Thakrala

Ejecutivos de Fortrea Holdings Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Mr. William J. (Bill) Sharbaugh
Mr. William J. (Bill) Sharbaugh
Director
Director
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
North America
344.30M
48.47%
Europe
218.70M
30.79%
Other
147.30M
20.74%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Otro
55.93%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Otro
55.93%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
45.71%
Hedge Fund
24.43%
Investment Advisor/Hedge Fund
22.87%
Research Firm
13.87%
Bank and Trust
2.55%
Pension Fund
2.34%
Individual Investor
0.52%
Family Office
0.39%
Sovereign Wealth Fund
0.05%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
948
101.58M
111.87%
-11.06M
2025Q2
941
91.16M
100.39%
-22.39M
2025Q1
942
95.79M
105.84%
-17.15M
2024Q4
898
97.88M
109.12%
-17.67M
2024Q3
853
101.51M
113.29%
-12.93M
2024Q2
825
103.91M
116.10%
+693.93K
2024Q1
782
93.40M
104.47%
-524.01K
2023Q4
716
91.67M
103.23%
-7.08M
2023Q3
616
90.69M
102.13%
+51.44M
2023Q2
43
6.20M
7.00%
+6.20M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
12.74M
14.03%
+1.79M
+16.37%
Jun 30, 2025
The Vanguard Group, Inc.
8.51M
9.37%
-1.34M
-13.61%
Jun 30, 2025
Goldman Sachs & Company, Inc.
7.74M
8.53%
+7.70M
+19444.90%
Jun 30, 2025
AQR Capital Management, LLC
6.52M
7.18%
+5.42M
+494.84%
Jun 30, 2025
Corvex Management LP
4.51M
4.97%
+33.63K
+0.75%
Jun 30, 2025
State Street Investment Management (US)
4.43M
4.88%
+1.17M
+35.82%
Jun 30, 2025
Sessa Capital
3.99M
4.4%
-700.00K
-14.91%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.98M
3.28%
-1.07M
-26.50%
Jun 30, 2025
Starboard Value LP
2.50M
2.75%
-220.86K
-8.13%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.17M
2.39%
+589.14K
+37.23%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
Brandes US Small-Mid Cap Value ETF
1.13%
Invesco S&P Spin-Off ETF
0.83%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco S&P SmallCap 600 Pure Value ETF
0.19%
Invesco S&P SmallCap 600 Revenue ETF
0.17%
Schwab Fundamental U.S. Small Company ETF
0.14%
Humankind US Stock ETF
0.12%
SPDR S&P 600 Small Cap Value ETF
0.11%
iShares S&P Small-Cap 600 Value ETF
0.11%
ProShares Ultra Nasdaq Biotechnology
0.08%
Ver más
Brandes US Small-Mid Cap Value ETF
Proporción1.13%
Invesco S&P Spin-Off ETF
Proporción0.83%
Invesco S&P SmallCap Health Care ETF
Proporción0.49%
Invesco S&P SmallCap 600 Pure Value ETF
Proporción0.19%
Invesco S&P SmallCap 600 Revenue ETF
Proporción0.17%
Schwab Fundamental U.S. Small Company ETF
Proporción0.14%
Humankind US Stock ETF
Proporción0.12%
SPDR S&P 600 Small Cap Value ETF
Proporción0.11%
iShares S&P Small-Cap 600 Value ETF
Proporción0.11%
ProShares Ultra Nasdaq Biotechnology
Proporción0.08%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI